Inhaled nitric oxide does not influence bleeding time or platelet function in healthy volunteers

European Journal of Clinical Investigation

Volumn 29, Issue 11, 1999, Pages 953-959

  Albert, J ^a   Norman, M ^a   Wallen N H ^a   Frostell, C ^a   Hjemdahl, P ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bleeding time; Flow cytometry; Nitric oxide; Platelet aggregation; Skin perfusion

Indexed keywords

ACETYLSALICYLIC ACID; NITRIC OXIDE; PADGEM PROTEIN;

ADULT; ARTICLE; BLEEDING; BLEEDING TIME; FLOW CYTOMETRY; HUMAN; HUMAN EXPERIMENT; INHALATIONAL DRUG ADMINISTRATION; LASER DOPPLER FLOWMETRY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE DYSFUNCTION; VOLUNTEER; WOUND;

ADMINISTRATION, INHALATION; ADULT; BLEEDING TIME; BLOOD PLATELETS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; MALE; NITRIC OXIDE; P-SELECTIN; PLACEBOS; PLATELET ACTIVATION; REFERENCE VALUES; SKIN; WOUNDS AND INJURIES;

EID: 0032759080     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00560.x     Document Type: Article

References (31)

1. 1 Pepke-Zaba J, Higenbottom T, Dinh-Xuan T, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet, 1991;338:1173-4.
2. 2 Loh E, Stamler JS, Hare JM, Loscalzo J, Colucci WS. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation, 1994;90:2780-5.
3. 3 Rossaint R, Falke K, Løpez F, Slama K, Pison U, Zapol W. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med, 1993;328:399-405.
4. 4 Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide. A Selective Pulmonary Vasodilator Reversing Hypoxic Pulmonary Vasoconstriction [published erratum appears in circulation 1991 November, 1991;84(5):2212]. Circulation, 1991;83:2038-47.
5. 5 Frostell CG, Lönnqvist PA, Sonesson SE, Gustafsson LE, Löhr G, Noack G. Near fatal pulmonary hypertension after surgical repair of congenital diaphragmatic hernia. Anaesthesia, 1993;48:679-83.
6. 6 Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms [see comments]. Science, 1992;258;1898-90.
7. 7 Rimar S, Gillis N. Selective Pulmonary Vasodilation by Inhaled Nitric Oxide Is Due to Hemoglobin Inactivation. Circulation, 1993;88:2884-7.
8. 8 Högman M, Frostell C, Arnberg H, Hedenstierna G. Bleeding time prolongation and NO inhalation: letter. Lancet, 1993;341:1664-5.
9. 9 Högman M, Frostell C, Arnberg H, Sandhagen B, Hedenstierna G. Prolonged bleeding time during nitric oxide inhalation in the rabbit. Acta Physiol Scand, 1994;151:125-9.
10. 10 Albert J, Wallén H, Bröijersen A, Frostell C, Hjemdahl P. Effects of inhaled nitric oxide compared with aspirin on platelet function in vivo in healthy subjects. Clin Sci, 1996;91:225-31.
11. 11 Kermarrec N, Zunic P, Beloucif S, Benessiano J, Drouet L, Payen D. Impact of inhaled nitric oxide on platelet aggregation and fibrinolysis in rats with endotoxic lung injury. Am J Respir Crit Care Med, 1998;158:833-9.
12. 12 George T, Johnson K, Bates J, Segar J. The effect of inhaled nitric oxide therapy on bleeding time and platelet aggregation in neonates. J Pediatr, 1998;4:731-4.
13. 13 Krejcy K, Schmetterer L, Kastner J et al. Role of nitric Oxide in hemostatic system activation in vivo in humans. Arterioscler Thromb Vasc Biol 1995;15:2063-7.
14. 14 Samama CM, Diaby M, Fellahi JL et al. Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology, 1995;83:56-65.
15. 15 Lee J, Adrie C, Jacob H, Roberts J, Zapol W, Bloch K. Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury. Circ Res, 1996;78:337-42.
16. 16 Radomski MW, Palmer RMJ, Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Comm, 1987;3:1482-9.
17. 17 Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet, 1987;ii:1057-8.
18. 18 Radomski MW, Palmer RM, Moncada S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA, 1990;87:5193-7.
19. 19 Cheung P, Salas E, Peliowski A, Etches P, Schulz R, Radomski M. Inhaled nitric oxide inhibits platelet aggregation in critically ill neonates. Ped Res, 1997;41:143A [Abstract 843].
20. 20 Gries A, Bode C, Peter K et al. Inhaled nitric oxide inhibits human platelet aggregation, P-selectin expression, and fibrinogen binding in vitro and in vivo. Circulation, 1998;97:1481-7.
21. 21 De Caterina R, Lanza M, Manca G, Strata GB, Maffei S, Salvatore L. Bleeding time and bleeding: an analysis of the relationship of the bleeding time test with parameters of surgical bleeding. Blood, 1994;84:3363-70.
22. 22 Janes S, Wilson D, Chronos N, Goodall A. Evaluation of whole blood cytometric detection of platelet bound fibrinogen on normal subjects and patients with activated platelets. Thromb Haemost, 1993;70:659-66.
23. 23 Shattil S, Cunningham M, Hoxie J. Detection or activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood, 1987;70:307.
24. 24 Warkentin T, Powling M, Hardisty R. Measurements of fibrinogen binding to platelets in whole blood by flow cytometry: a micromethod for detection of platelet activation. Br J Haematol, 1990;76:387-94.
25. 25 Nilsson GE, Tenland T, Öberg PÅ. Evaluation of laser Doppler flowmeter for measurements of tissue blood flow. IEET Trans Biomed Eng BME, 1980;10:597-604.
26. 26 Smits GJ, Roman RJ, Lombard JH. Evaluation of laser Doppler flowmetry as a measure of tissue blood flow. J Appl Physiol, 1986;61:666-72.
27. 27 Norman M, Martin H, Herin P. Biological zero in laser Doppler perfusion measurements: studies in neonates. Acta Paediatr, 1995;84:457-9.
28. 28 Rodgers RPC, Levin J. A critical reappraisal of bleeding time. Thromb Haemost, 1990;16:1-20.
29. 29 Rinder CS, Student LA, Bonan JL, Rinder HM, Smith BR. Aspirin does not inhibit adenosine diphosphate-induced platelet alpha-granule release. Blood, 1993;82:505-12.
30. 30 Chronos NA, Wilson DJ, Janes SL, Hutton RA, Buller NP, Goodall AH. Aspirin does not affect the flow cytometric detection of fibrinogen binding to, or release of alphagranules or lysosomes from, human platelets. Clin Sci, 1994;87:575-80.
31. 31 Varela A, Runge A, Ignarro L, Chaudhuri G. Nitric oxide and prostacyclin inhibit fetal platelet aggregation: A response similar to that observed in adults. Am J Obstet Gynecol, 1992;167:1599-60.